Scarica l'app Stockscreener
0.73
1.39%
0.01
Dopo l'orario di chiusura:
.70
-0.03
-4.11%
Polyrizon Ltd Borsa (PLRZ) Ultime notizie
Polyrizon Ltd Inc. (PLRZ) Price Performance: How to Use Technical Analysis to Make Trading Decisions - investchronicle.com
Polyrizon’s nasal drug delivery system shows promising results By Investing.com - Investing.com South Africa
Polyrizon Reports Promising Results Demonstrating Successful Internasal Delivery of its Innovative Hydrogel Formulation for CNS Therapeutics - MarketScreener
Polyrizon’s nasal drug delivery system shows promising results - Investing.com Australia
Polyrizon Announces Promising Preclinical Results for CNS Therapeutics - TipRanks
Revolutionary Nasal Drug Delivery System Could Transform Treatment of Opioid Overdose and Epilepsy - Stock Titan
Smart Digital Group And Polyrizon See Unusual Market Moves - Finimize
Polyrizon Ltd. Announces Reverse Share Split Effective May 27, 2025 - TipRanks
Polyrizon recives Nasdaq delisting notice - MSN
Polyrizon faces Nasdaq delisting over shareholder dilution By Investing.com - Investing.com India
Polyrizon Stock Price, Quotes and Forecasts | NASDAQ:PLRZ - Benzinga
Polyrizon faces Nasdaq delisting over shareholder dilution - Investing.com Australia
Polyrizon Receives Nasdaq Delisting Notice Amid Shareholder Concerns - TipRanks
Polyrizon Receives Nasdaq Delisting Notice - marketscreener.com
Polyrizon receives noncompliance letter from Nasdaq - TipRanks
Polyrizon Announces Receipt of Nasdaq Delisting Notice - The Manila Times
Polyrizon announces preclinical data on nasal protection platform - TipRanks
Polyrizon Emerges with Positive Preclinical Data on Nasal Protection Platform - Bluefield Daily Telegraph
Revolutionary Nasal Drug Delivery Platform Achieves Perfect Coverage Score in Latest Tests - Stock Titan
Pennies on the Rise: HCTI, SWISF, ADHC, NCNA Gain Traction Amid LargeCap Uncertainty – More Stocks Inside - FinancialContent
Polyrizon Ltd. Increases Outstanding Shares Following Warrant Exercises - TipRanks
Polyrizon Ltd. Announces Increase in Outstanding Shares Following Warrant Exercises - TipRanks
Nasdaq Gains Over 100 Points; Sony Group Posts Upbeat Earnings - Benzinga
Nasdaq Rises Over 1%; Under Armour Posts Strong Q4 Sales - Benzinga
Polyrizon begins preclinical studies for seizure treatment - Investing.com Australia
Polyrizon announces initiation of preclinical studies for Benzodiazepines - TipRanks
Polyrizon Targets $3.15B Epilepsy Market with Preclinical Studies for Innovative Rescue Treatment - The Manila Times
Polyrizon begins preclinical studies for seizure treatment By Investing.com - Investing.com Nigeria
Why Coinbase Global Shares Are Trading Higher By Over 9%; Here Are 20 Stocks Moving Premarket - Benzinga
Polyrizon, Pheton, AirSculpt: Top 3 Healthcare Stocks With Soaring Weekly Retail Interest - MSN
Promising Small Cap Stocks To Follow NowMay 4th - MarketBeat
Best Small Cap Stocks To ConsiderMay 3rd - MarketBeat
Polyrizon Ltd. Announces 1-for-10 Reverse Share Split Effective May 5, 2025 - TipRanks
US Stocks Likely To Open Lower After S&P 500's 9-Day Streak: 'Any De-Escalation In Trade Tensions Should Be Positive,' Says Expert - Benzinga
Why Faraday Future Intelligent Electric Shares Are Trading Higher By 6%; Here Are 20 Stocks Moving Premarket - Benzinga
Polyrizon, Pheton, AirSculpt: Top 3 Healthcare Stocks With Soaring Weekly Retail Interest By Stocktwits - Investing.com India
Upcoming Stock Splits This Week (May 5 to May 9) – Stay Invested - TipRanks
PLRZPolyrizon Ltd Latest Stock News & Market Updates - Stock Titan
Promising Biotech Stocks To Watch Today – May 2nd - Defense World
United States shares higher at close of trade; Dow Jones Industrial Average up 1.39% - Investing.com India
Nasdaq Surges Over 300 Points; Apple Shares Fall After Q2 Results - Benzinga
PLRZ Stock: Exploring Polyrizon Ltd’s Growth - investchronicle.com
Polyrizon (PLRZ) Stock Skyrocketed Over 240% Today: What's Going On? - Benzinga
PLRZ’s price-to-cash ratio: How it affects the stock’s valuation. - uspostnews.com
1.06%
1.67%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):